Connor, Clark & Lunn Investment Management Ltd. - TCR2 THERAPEUTICS INC ownership

TCR2 THERAPEUTICS INC's ticker is TCRR and the CUSIP is 87808K106. A total of 81 filers reported holding TCR2 THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.39 and the average weighting 0.1%.

Quarter-by-quarter ownership
Connor, Clark & Lunn Investment Management Ltd. ownership history of TCR2 THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$26,000
-80.6%
14,362
-50.1%
0.00%
-100.0%
Q4 2021$134,000
-35.3%
28,760
+18.3%
0.00%0.0%
Q3 2021$207,00024,3170.00%
Other shareholders
TCR2 THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 4,050,865$11,748,0004.96%
MPM BioImpact LLC 3,370,982$9,776,0002.72%
TANG CAPITAL MANAGEMENT LLC 3,641,606$10,561,0001.60%
Newtyn Management, LLC 692,799$2,009,0000.38%
K2 PRINCIPAL FUND, L.P. 1,078,070$3,126,0000.34%
HARBOR CAPITAL ADVISORS, INC. 64,341$187,0000.14%
Redmile Group, LLC 1,094,645$3,174,0000.12%
Artal Group S.A. 750,000$2,175,0000.12%
Oasis Management Co Ltd. 200,000$580,0000.10%
X-Square Capital, LLC 31,919$93,0000.06%
View complete list of TCR2 THERAPEUTICS INC shareholders